- Open Access
Synovial biopsy for establishing a definite diagnosis in undifferentiated chronic knee monoarthritis
BMC Musculoskeletal Disorders volume 24, Article number: 23 (2023)
Undifferentiated arthritis is a condition in which the problem cannot be classified into any definite diagnosis category. Various methods have been suggested to clarify the definite diagnosis in this class. The synovial biopsy is suggested as the last diagnostic approach to determine the precise histopathological diagnosis. In this study, we aimed to evaluate the efficacy of synovial biopsy for establishing a definite diagnosis in patients with undifferentiated chronic knee monoarthritis.
The present retrospective case series was conducted in 2005 in the rheumatology research center of Shariati hospital and the 501 hospital in Tehran, Iran. The study included the synovial biopsy of patients with chronic knee monoarthritis who did not have a definite diagnosis after all the diagnostic steps before the synovial biopsy. Pathology slides of the patients’ synovial biopsy were reevaluated with a senior expert pathologist.
Eighty patients with a mean age of 37.6 ± 17.32 years (range: 6–68) were included, of whom 50% were female. The gap time between the onset of knee monoarthritis and the decision-making for synovial biopsy was 14.34 ± 19.61 months. Histopathologic evaluations revealed non-specific synovitis in 65% of the patients and a definite diagnosis in 35%. The most common definite diagnosis was rheumatoid arthritis (9%), followed by septic arthritis (5%). The most common pathologic findings were endothelial proliferation (89%) and synovial proliferation (88%), and the most common infiltrating cell was lymphocyte (54%). Patients with non-specific synovitis were more likely to have neovascularization, cellular infiltration (p-value < 0.001), synovial proliferation, endothelial proliferation (p-value = 0.001), pannus formation (p-value = 0.009), and fibrosis (p-value = 0.022) compared to the patients with a definite pathologic diagnosis. However, age, gender, and the gap time between disease symptoms to synovial biopsy were not significantly different between the different groups of diagnosis (p-value > 0.05).
Non-specific synovitis remains the most common histopathologic finding, highlighting the importance of physician expert opinion for most of the patients with undifferentiated chronic knee monoarthritis. Studies with larger samples and immunohistochemistry analyses are needed to clarify this uncategorized entity further.
Musculoskeletal disorders are among the most prevalent reasons for seeking medical help. It is estimated that up to 30% of the population experience at least one musculoskeletal complaint during their lifetime [1, 2]. Among musculoskeletal complaints, disorders with articular origin are prominent. Specifically, knee involvement accounts for one of the most common reasons for chronic pain in the general population . Compared to periarticular lesions, articular involvements tend to last longer than six weeks and become chronic, can affect a diverse number of joints, and cause pain with inflammatory features.
Among the different types of joint involvement, revealing the reason for chronic monoarthritis poses a diagnostic challenge. The etiologies of chronic inflammatory monoarthritis can be classified as indolent infections (e.g., tuberculosis and brucellosis), fungal infections, gout and calcium pyrophosphate crystal deposition disease (CPPD), and immunoinflammatory arthritis. Immunoinflammatory arthritis could be due to autoimmune conditions like spondyloarthritis, systemic lupus erythematosus, or rheumatoid arthritis (RA). Chronic non-inflammatory monoarthritis is attributed to four major groups of osteoarthritis, osteonecrosis, neuropathic joint, and pigmented villonodular synovitis [4, 5]. In addition to the mentioned categories, undifferentiated arthritis refers to the condition that arthritis could not be categorized as rheumatoid arthritis or other classes of definite arthritis. Undifferentiated arthritis might indicate the early phase of an established disease or remain an entity that does not fit into any category of rheumatologic diagnoses [6, 7]. Establishing a definite diagnosis for undifferentiated arthritis disorders is a long-standing challenge in rheumatology. As knee arthritis is one of the most common sites of involvement in undifferentiated monoarthritis , exploring the etiologies behind this phenomenon is particularly important.
Evaluation of chronic monoarthritis starts with a thorough history and physical examination and continues with appropriate laboratory and imaging studies. In rare cases, a synovial biopsy is undertaken to achieve a precise diagnosis. Histopathological examination of synovial specimens may be valuable in making an early diagnosis . In addition to the diagnosis, findings of synovial biopsy have prognostic value [6, 10] and alter under response to the treatment . It is reported that, specifically in undifferentiated arthritis, synovial tissue biopsy can facilitate the diagnostic process [6, 12].
As the diagnosis of chronic undifferentiated monoarthritis is problematic, synovial tissue biopsy might offer valuable information as the last diagnostic utility and aid in reaching a precision medicine approach. Synovial biopsy findings are not extensively reviewed in the literature for chronic knee monoarthritis [6, 7]. Thus, we aimed to evaluate synovial tissue biopsy’s clinical implication and efficacy for establishing definite diagnoses in patients previously labeled as having chronic undifferentiated knee monoarthritis.
The present retrospective case series was conducted in 2005 in the rheumatology research center of Shariati hospital and the 501 hospital, two tertiary referral teaching hospitals in Tehran, Iran. The study sample included all the patients from the rheumatology clinic of the two mentioned hospitals between 1998 and 2004 with chronic knee monoarthritis who had no definite diagnosis after all the preliminary diagnostic steps and had undergone synovial biopsy as the last diagnostic tool. The preliminary diagnostic tests included complete blood count (CBC), erythrocyte sedimentation rate (ESR), C-Reactive Protein (CRP), uric acid, thyroid stimulating hormone (TSH), glycosylated hemoglobin, urine analysis, antinuclear antibody (ANA), rheumatoid factor, anti-cyclic citrullinated peptides antibodies (APCAs), arthrocentesis, and x-ray radiography of the involved joint. To evaluate indolent infections, we tested the patients with purified protein derivate for tuberculosis, and wright, coombs wright, and 2-mercaptoethanol for brucellosis .
Exclusion criteria were prior use of biologic agents, previous intra-articular injection of corticosteroids, active infections, history of synovial biopsy, duration of the symptoms less than six weeks, and a history of surgery in the target joint (excluding arthroscopy). Additionally, patients with samples taken only from the surrounding tissues or with incorrect slide preparation and staining techniques, improper transport and maintenance of the slides, and mislabeled or missing slides were not included.
An expert rheumatologist performed the biopsy in a closed method with Paul and Beakle needle (Fig. 1). Concomitant synovial fluid and blood sampling were done at the time of the biopsy and were sent for culture and biochemistry analysis. The biopsy for some patients who were referred from the orthopedics ward was taken through an open biopsy technique. An expert pathologist reevaluated all synovial biopsy slides, and the pathologic findings were recorded. Specimens were evaluated regarding synovial proliferation, endothelial proliferation, neovascularization, granuloma, giant cells, pannus formation, fibrosis, hemosiderin deposition, infiltration of inflammatory cells, and any evidence of invasion, dysplasia, or neoplasm. The diagnosis of septic arthritis was confirmed by either observing the evidence of infection in histopathologic examination or positive culture of synovial fluid, synovial tissue, or blood. Where the pathologist could not attribute any definite diagnosis to the examined sample, the sample was labeled as having non-specific synovitis.
A data collection form was designed based on the study parameters. Information was gathered through data collection forms concerning age, gender, duration of symptoms, the involved joint, and histopathologic findings. The relevant data were extracted from the medical and pathology records of the patients.
Statistical analysis was performed with SPSS version 16 for Windows. Descriptive statistics were reported as mean, standard deviation, and range. Frequencies were reported as the total number and percentage. Since the Kolmogorov-Smirnov test confirmed the normal distribution of the sample, Student’s T-test and chi-square test were used for inter-group comparisons. The statistical significance level was considered as p-value < 0.05.
One hundred and forty tissue samples were evaluated in the present study, of which 60 were excluded. As a result, 80 patients with chronic knee monoarthritis were eventually included. Gender distribution was precisely equal (1:1). The mean age was 37.6 ± 17.32 years (range: 6–68 years), and the most common age group was 20–29 years (21 patients, 26%, Fig. 2). None of the patients had undergone arthroscopy. The gap between the onset of knee monoarthritis and the decision-making for synovial biopsy was 14.34 ± 19.61 months. The mentioned gap time was zero to six months in 23 (45%), six to twelve months in 15 (29%), and more than twelve months in 13 patients (26%). The right knee was involved in the majority (40 patients, 58%).
The most common final opinion of the pathologist was “non-specific synovitis” in 52 samples (65%). In patients with a definite diagnosis, the most common diagnosis was rheumatoid arthritis in seven (9%), followed by septic arthritis in four (5%). Three (4%) of the diagnoses were malignant. The detailed frequency of the diagnoses is shown in Table 1.
The most common pathologic finding of synovial biopsy specimens was endothelial proliferation in 71 patients (89%), and the most common infiltrating cell was lymphocyte in 43 samples (54%). The details of the pathologic findings are listed in Table 2.
Overall, 52 patients (65%) were diagnosed with non-specific synovitis, and 28 patients (35%) were diagnosed with a definite histopathologic diagnosis. The “non-specific synovitis” group included 28 females (54%) and 24 males (46%), while the “definite diagnoses” group consisted of 12 females (43%) and 16 males (57%). Statistical analysis did not show a significant difference between the patients with or without a definite diagnosis regarding gender distribution (p-value = 0.348). The presence of a definite histopathologic diagnosis was not associated with the gap from the onset of the disease to the decision-making for synovial biopsy (p-value = 0.181). The comparison of age and gap duration between disease onset and synovial biopsy did not show any significant difference between the different groups of diagnosis (p-values = 0.248 and 0.929, respectively).
Patients with non-specific synovitis were more likely to have neovascularization, cellular infiltration (p-value < 0.001), synovial proliferation, endothelial proliferation (p-value = 0.001), pannus formation (p-value = 0.009), and fibrosis (p-value = 0.022) compared to the patients with a definite pathologic diagnosis. The details of the histopathologic findings in each pathologic diagnosis are discussed in Table 3.
The synovial biopsy is an invasive approach and is not routinely conducted for diagnostic purposes. However, examination of synovial tissue can assist in the diagnosis of some conditions like rheumatoid arthritis (RA), tuberculosis, fungal involvements, and some bacterial infections. The synovial biopsy is considered the final and last choice for establishing the diagnosis of chronic monoarthritis. It is assumed that in cases of undifferentiated arthritis, a synovial biopsy can facilitate the diagnostic process [6, 14]. Results of our study showed that synovial biopsy could establish a definite diagnosis in one-third of cases with undifferentiated chronic knee monoarthritis. However, histopathologic examination revealed nothing but non-specific synovitis in the other two-thirds of the cases. In other studies on chronic monoarthritis, it was observed that the cause of arthritis in 16–62% of cases remains undefined [8, 14, 15].
In the present study, the definite diagnoses were mainly rheumatoid arthritis (9%) and septic arthritis (5%). Some previous studies on patients with undifferentiated chronic monoarthritis have revealed rheumatoid arthritis and spondyloarthropathy as the most frequent diagnoses [8, 16]. Another study on patients with chronic monoarthritis reported RA in 9% and crystal arthropathy in 7.4% of cases . Consistent with our findings, RA ranks as the most common definite diagnosis in cases with a previous diagnosis of undifferentiated chronic monoarthritis. The histopathologic features of non-specific synovitis and rheumatoid arthritis are very similar [11, 17]. Our study demonstrated a higher prevalence of neovascularization, cellular infiltration, synovial and endothelial proliferation, pannus formation, and fibrosis in patients with non-specific synovitis than the ones with a definite histopathologic diagnosis. Among the findings of earlier stages of RA are synovial infiltration, endothelial proliferation, high vascularity, and fibrin deposition. Most of these features are found in the early stages of rheumatoid arthritis [17,18,19] and other types of synovitis as well . Based on what was mentioned, it can be deduced that RA begins with non-specific synovitis and gradually transits into established RA. The diagnostic challenge in distinguishing early phases of RA from non-specific synovitis is common. Repeated serial biopsies may confirm the diagnosis of RA in most cases with non-specific synovitis, although its invasiveness limits its use in clinical practice. Using molecular and immunohistochemistry findings might help differentiate these two entities .
The second most common diagnosis in the present study was septic arthritis. The diagnosis of septic arthritis was confirmed with a positive culture of the samples taken from the patients or evidence of infection observed by the pathologist. Given the negative culture in some cases of septic arthritis, some other factors may aid in making the diagnosis and preventing joint destruction. Synovial white blood cell count , neutrophil count [21, 22], and the neutrophil-to-lymphocyte ratio  are among the suggested surrogate diagnostic markers for septic arthritis. The onset of septic arthritis is followed by chemo-attraction of neutrophils as the main immune cells combating the infection. Neutrophils act against the spread of infection through the entrapment of microorganisms with neutrophil extracellular traps, phagocytosis of the microorganisms, and recruitment of additional immune cells to the infected joint. Based on previous studies, the increased neutrophil count predicts joint infection and damage . Given the low sensitivity of synovial white blood cells and neutrophil count (56% and 60–65%), the neutrophil-to-lymphocyte ratio can be recruited as a sensitive surrogate marker of diagnosis. A previous study found 78% sensitivity and 81% specificity for synovial neutrophil-to-lymphocyte ratio larger than 25 and recommended this marker to be considered in clinical decision-making . The present study adds to the present literature regarding the similarities of undifferentiated monoarthritis and rheumatoid arthritis and emphasizes the follow-up of these patients. The most important limitations of our study were the small sample size, the study’s retrospective nature, and the lack of patient follow-up. Another limitation of the present study was the blind biopsy that restricted the targeted sampling of the synovium. Arthroscopy is a recently-introduced modality that allows macroscopic assessment of the synovium and aids in diagnosis and targeted biopsy . Recent studies demonstrate the superiority of ultrasound and arthroscopy in guiding the biopsies and yielding better synovial samples. The mentioned superiority is specifically evident in biopsies taken from large joints, including the knees . Thus, we suggest assessing the findings with biopsies taken with either arthroscopy or the guide of ultrasound. Another limitation was the lack of genetic, molecular, and immunohistochemistry evaluation of the samples. Evaluating these variables in future studies can optimize the utility of synovial biopsy for making a definite diagnosis of chronic knee monoarthritis.
Although synovial biopsy can elucidate the diagnosis in about one-third of the cases with undifferentiated chronic knee monoarthritis, non-specific synovitis remains the most common pathologic label in evaluating chronic knee monoarthritis. As a result, the main decision-making for the diagnosis in the remaining two-thirds of the monoarthritis patients is based on the physician’s expert opinion and the results of the patients’ future follow-ups.
Availability of data and materials
The dataset used and analyzed during the current study is available from the corresponding author on reasonable request.
Calcium pyrophosphate crystal deposition disease
Complete blood count
Erythrocyte sedimentation rate
Thyroid stimulating hormone
Anti-cyclic citrullinated peptides antibodies
Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ. 2003;81(9):646–56.
Woolf AD, Kristina A. Understanding the burden of musculoskeletal conditions. BMJ. 2001;322(7294):1079–80
Noormohammadpour P, Mansournia MA, Koohpayehzadeh J, Asgari F, Rostami M, Rafei A, et al. Prevalence of chronic neck pain, low back pain, and knee pain and their related factors in community-dwelling adults in Iran. Clin J Pain. 2017;33(2):181–7.
Malaviya AN. A patient with musculoskeletal [MSK] pains-clinical approach. Bull Kuwait Inst Med Specialization. 2004;3(2):73–82.
Mohana-Borges AV, Chung CB, Resnick D. Monoarticular arthritis. Radiol Clin North Am. 2004;42(1):135–49.
Manzo A, Bugatti S, Rossi S. Clinical applications of synovial biopsy. Front Med. 2019;6:102.
Thevissen K, Vercoutere W, Bombardier C, Landewé RB. Diagnostic and prognostic value of synovial biopsy in adult undifferentiated peripheral inflammatory arthritis: a systematic review. J Rheumatol Suppl. 2011;87:45–7.
Jeong H, Kim AY, Yoon HJ, Park EJ, Hwang J, Kim H, et al. Clinical courses and predictors of outcomes in patients with monoarthritis: a retrospective study of 171 cases. Int J Rheum Dis. 2014;17(5):502–10.
Ali M, Veale D, Reece R, Quinn M, Henshaw K, Zanders E, et al. Overexpression of transcripts containing LINE-1 in the synovia of patients with rheumatoid arthritis. Ann Rheum Dis. 2003;62(7):663–6.
Cunnane G, FitzGerald O, Hummel KM, Youssef PP, Gay RE, Gay S, et al. Synovial tissue protease gene expression and joint erosions in early rheumatoid arthritis. Arthr Rhuem. 2001;44(8):1744–53.
Small A, Wechalekar MD. Synovial biopsies in inflammatory arthritis: precision medicine in rheumatoid arthritis. Expert Rev Mol Diagn. 2020;20(3):315–25.
Saaibi DL, Schumacher HR Jr. Percutaneous needle biopsy and synovial histology. Baillière’s Clin Rheumatol. 1996;10(3):535–54.
Avijgan M, Rostamnezhad M, Jahanbani-Ardakani H. Clinical and serological approach to patients with brucellosis: a common diagnostic dilemma and a worldwide perspective. Microb Pathog. 2019;129:125–30.
Ma L, Cranney A, Holroyd-Leduc JM. Acute monoarthritis: what is the cause of my patient’s painful swollen joint? CMAJ. 2009;180(1):59–65.
Rasheed U. Diagnosis of patients presenting with monoarthritis. Ann Pak Inst Med Sci. 2012;8(1):14–8.
Inaoui R, Bertin P, Preux P-M, Trèves R. Outcome of patients with undifferentiated chronic monoarthritis: retrospective study of 46 cases. Joint Bone Spine. 2004;71(3):209–13.
Raza K, Falciani F, Curnow SJ, Ross EJ, Lee C-Y, Akbar AN, et al. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res therapy. 2005;7(4):1–12.
van de Sande MG, de Hair MJ, Schuller Y, van de Sande GP, Wijbrandts CA, Dinant HJ, et al. The features of the synovium in early rheumatoid arthritis according to the 2010 ACR/EULAR classification criteria. PLoS ONE. 2012;7(5):e36668.
Neumann E, Lefèvre S, Zimmermann B, Gay S, Müller-Ladner U. Rheumatoid arthritis progression mediated by activated synovial fibroblasts. Trends Mol Med. 2010;16(10):458–68.
Triaille C, Lauwerys BR. Synovial tissue: turning the page to precision medicine in arthritis. Front Med. 2019;6:46.
Margaretten ME, Kohlwes J, Moore D, Bent S. Does this adult patient have septic arthritis? JAMA. 2007;297(13):1478–88.
Boff D, Crijns H, Teixeira MM, Amaral FA, Proost P. Neutrophils: Beneficial and Harmful Cells in Septic Arthritis. Int J Mol Sci. 2018;19(2):468.
Varady NH, Schwab PE, Kheir MM, Dilley JE, Bedair H, Chen AF. Synovial fluid and serum neutrophil-to-lymphocyte ratio: novel biomarkers for the diagnosis and prognosis of native septic arthritis in adults. J Bone Joint Surg Am. 2022;104(17):1516–22.
Wechalekar MD, Smith MD. Utility of arthroscopic guided synovial biopsy in understanding synovial tissue pathology in health and disease states. World J Orthop. 2014;5(5):566–73.
Humby F, Romão VC, Manzo A, Filer A, Bugatti S, Vieira-Sousa E, et al. A Multicenter Retrospective Analysis evaluating performance of synovial biopsy techniques in patients with inflammatory arthritis: arthroscopic Versus Ultrasound-Guided Versus Blind Needle Biopsy. Arthritis Rheumatol. 2018;70(5):702–10.
The authors would like to thank Dr. Nasser Kamalian for reviewing and reevaluating the pathology slides.
Conflict of interest
Ethics approval and consent to participate
The study was done under the supervision of the ethics committee at AJA University of Medical Sciences and in line with the declaration of Helsinki. Due to the retrospective nature of the study, ethics code acquisition was not essential. All patients gave informed consent to participate in the study.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Soroosh, S.G., Ghatfan, A., Farbod, A. et al. Synovial biopsy for establishing a definite diagnosis in undifferentiated chronic knee monoarthritis. BMC Musculoskelet Disord 24, 23 (2023). https://doi.org/10.1186/s12891-023-06138-x
- Knee monoarthritis
- Synovial biopsy
- Chronic synovitis
- Undifferentiated arthritis
- Monoarticular arthritis